Adding an immunotherapy drug to chemotherapy made breast cancer treatment more effectiveOriginal image by DepositphotosA phase 3 clinical trial found that adding nivolumab, a targeted immunotherapy drug, to chemotherapy nearly doubled cure rates for patients with the most common type of breast cancer, estrogen receptor-positive (ER+)/HER2-negative (HER2–). This finding signals a potential shift in treatment...
AI rivals doctors’ ability to interpret mammograms, a real-world study with nearly 500,000 participants in Germany suggests. Credit: DepositphotosResearchers reported on January 7 in Nature Medicine that AI-assisted mammogram analysis helped doctors detect one additional cancer case for every 1,000 women screened compared to when the technology wasn’t used. This finding comes from the...
Manuka honey, produced from nectar from the mānuka tree, has potent anticancer propertiesDepositphotosPreliminary studies indicate that Manuka honey can decrease breast cancer cell growth by 84% while sparing healthy cells and causing minimal side effects. This suggests potential for developing a natural, non-toxic cancer treatment, either as a supplement or a standalone therapy.Nutraceuticals—essentially a...
Three-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Credit: NCI Center for Cancer Research, National Cancer Institute, National Institutes of HealthScientists have determined a protein that, when present in significant quantities in breast cancer tumors, is a signal of whether DNA-damaging...
AI making mistakesExamining breast-cancer tumors with artificial intelligence can enhance healthcare efficiency and results. However, specialists must proceed carefully, considering that identical technological jumps previously caused greater false-positive tests rates and over-treatment.That is according to a new article in JAMA Health Forum co-written by Joann G. Elmore, MD, MPH, a scientist at the UCLA Jonsson Comprehensive Cancer Center, the Rosalinde...
